Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Braingrade
Braingrade

Braingrade

Pre-Seed

Braingrade: A global neurotech leader developing neurostimulators for enhanced Alzheimer's care.

HQ
Wilmington, DE, US
Founded
2019
Overview
Compare
Fundraising
Employees

Braingrade, founded by a team of experienced executives and founders from leading neurotech companies, aims to revolutionize Alzheimer's care through advanced neurostimulation technology. The company's core mission is to enhance human cognition and extend the healthy lifespan of Alzheimer's patients by up to ten years, far surpassing the capabilities of current medications. Braingrade's primary product is an intelligent brain implant (DBS/BCI) designed to preserve brain health and improve the quality of life for those affected by Alzheimer's disease.

Notable figures affiliated with Braingrade include top memory enhancement researchers, neurosurgeons, and neurologists who contribute to the development of their innovative solutions. The company has garnered attention for its potential to significantly impact Alzheimer's treatment, positioning itself as a leader in the neurotech industry. Braingrade's achievements include pioneering advancements in brain-computer interface technology and setting new benchmarks for patient care in neurodegenerative diseases.

Braingrade - Similar Companies

Metabrain logo

Metabrain

BrainHealth logo

BrainHealth

Nia Therapeutics logo

Nia Therapeutics

Cognito Therapeutics logo

Cognito Therapeutics

cognitotx.com

BrainCo logo

BrainCo

brainco.tech

Epic Neuro logo

Epic Neuro

Neurosity logo

Neurosity

neurosity.co

Neuro42 logo

Neuro42

Craniometrix logo

Craniometrix

craniometrix.com

NeuroFieldz logo

NeuroFieldz

neurofieldz.com

MindRhythm logo

MindRhythm

mindrhythm.com

neuroFit logo

neuroFit

neurofit.tech

Sonera logo

Sonera

BrainRobotics logo

BrainRobotics

brainrobotics.com

Neurotype logo

Neurotype

Braingrade - Quick Facts

Who are Braingrade's competitors?

Companies similar to Braingrade include Metabrain, BrainHealth, Nia Therapeutics and Cognito Therapeutics.

When was Braingrade founded?

Braingrade was founded in 2019.

Where is Braingrade's headquarters located?

Braingrade's headquarters is located in Wilmington, DE, US.

When was Braingrade's last funding round?

Braingrade's most recent funding round was for $1M (USD) in October 2021.

How much has Braingrade raised to-date?

As of Oct 1, 2021, Braingrade has raised a total of $1M (USD).

How many employees does Braingrade have?

Braingrade has 17 employees as of Feb 4, 2024.

Braingrade - Classification

Industry
  • Hardware
Ownership
  • Venture Capital
Technology
  • AI
  • Machine Learning
Geographic Exposure
  • Global
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Neurostimulators
Tags
  • Biotech
  • Healthtech
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
SIC
  • 5000Wholesale Trade-durable Goods
  • 5040Professional And Commercial Equipment And Supplies
  • 5047Medical, Dental, And Hospital Equipment And Supplies
Show 14 more industry codes
NAICS
  • 513200Software Publishers
  • 330000Manufacturing
  • 510000Information
  • 620000Health Care and Social Assistance
  • 513000Publishing Industries
  • 623000Nursing and Residential Care Facilities
  • 513210Software Publishers
SIC
  • 3900Miscellaneous Manufacturing Industries
  • 7300Business Services
  • 8000Health Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 8040Offices And Clinics Of Other Health Practitioners
  • 7372Prepackaged Software
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified